Connor, Clark & Lunn Investment Management (CC&L)’s Calithera Biosciences, Inc CALA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-1,955
| Closed | -$174K | – | 1224 |
|
2020
Q1 | $174K | Sell |
1,955
-353
| -15% | -$31.4K | ﹤0.01% | 882 |
|
2019
Q4 | $264K | Buy |
2,308
+825
| +56% | +$94.4K | ﹤0.01% | 788 |
|
2019
Q3 | $92K | Buy |
1,483
+680
| +85% | +$42.2K | ﹤0.01% | 914 |
|
2019
Q2 | $63K | Buy |
+803
| New | +$63K | ﹤0.01% | 963 |
|
2017
Q4 | – | Sell |
-581
| Closed | -$183K | – | 880 |
|
2017
Q3 | $183K | Buy |
+581
| New | +$183K | ﹤0.01% | 762 |
|
2017
Q1 | – | Sell |
-510
| Closed | -$33K | – | 1040 |
|
2016
Q4 | $33K | Sell |
510
-200
| -28% | -$12.9K | ﹤0.01% | 864 |
|
2016
Q3 | $46K | Buy |
710
+185
| +35% | +$12K | ﹤0.01% | 803 |
|
2016
Q2 | $39K | Sell |
525
-110
| -17% | -$8.17K | ﹤0.01% | 840 |
|
2016
Q1 | $72K | Sell |
635
-160
| -20% | -$18.1K | ﹤0.01% | 781 |
|
2015
Q4 | $122K | Buy |
+795
| New | +$122K | ﹤0.01% | 743 |
|